Live Analyst Rating Changes 2857 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Elinor Leung
CLSA
Elinor Leung
CLSA
Wall Street Analyst
★★★★☆
#433
on 13Foresight · ranked by our own returns
33%
Success Rate
-4.6%
Average Return
4 of 12 calls profitable · -0.5% vs benchmark
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 33% of Elinor Leung's ratings turned a profit when each position was held for 1 year — averaging -4.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

24 Buy 0 Hold 0 Sell
Elinor's Stock Coverage 20 ratings · 2026-06-25
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
HK:3690
Meituan
 Nov 30, 2025 BUY Strong Buy
+76.7% avg upside
20 analysts
$135.00
93.88% Upside
 ·
HK:1024
Kuaishou Technology Class B
 Nov 20, 2025 BUY Strong Buy
+81.9% avg upside
18 analysts
$83.00
92.04% Upside
 ·
HK:1810
Xiaomi
 Nov 19, 2025 BUY Strong Buy
+94.4% avg upside
19 analysts
$60.00
165.30% Upside
 ·
HK:6618
JD Health International, Inc.
 Nov 14, 2025 BUY Strong Buy
+115.8% avg upside
4 analysts
$71.00
113.87% Upside
 ·
HK:0700
Tencent Holdings
Nov 14, 2025 BUY Strong Buy
+62.6% avg upside
22 analysts
$740.00
78.40% Upside
 ·
BABA
Alibaba
 Oct 02, 2025 BUY Strong Buy
+82.9% avg upside
48 analysts
$200.00
90.48% Upside
 -46.0%
BIDU
Baidu
 Sep 22, 2025 BUY Strong Buy
+49.9% avg upside
34 analysts
$160.00
43.20% Upside
 -23.9%
HK:0728
China Telecom
 Aug 15, 2025 BUY Strong Buy
+41.0% avg upside
7 analysts
$6.20
42.45% Upside
 ·
TCOM
Trip.com Group Sponsored ADR
 Nov 20, 2024 BUY Strong Buy
+43.5% avg upside
31 analysts
$77.00
65.96% Upside
 +8.3%
JD
JD
 Oct 31, 2024 BUY Strong Buy
+75.5% avg upside
30 analysts
$46.00
70.32% Upside
 -16.3%
BILI
Bilibili
 May 10, 2024 BUY Strong Buy
+96.7% avg upside
26 analysts
$16.80
0.17% Upside
 +24.6%
NTES
NetEase
 May 08, 2024 BUY Strong Buy
+19.8% avg upside
26 analysts
$136.00
11.91% Upside
 +13.3%
WB
Weibo
 Mar 04, 2024 SELL Hold
+132.2% avg upside
13 analysts
$10.00
35.83% Upside
 -33.6%
HK:9888
Baidu, Inc. Class A
 Oct 20, 2023 BUY Strong Buy
+51.2% avg upside
9 analysts
$170.00
62.37% Upside
 ·
PDD
PDD Holdings
 Aug 30, 2023 BUY Strong Buy
+54.2% avg upside
29 analysts
$114.00
45.99% Upside
 -2.1%
ATHM
AutoHome
 Nov 02, 2022 BUY Buy
+67.4% avg upside
15 analysts
$30.80
66.97% Upside
 -5.1%
IQ
Iqiyi
 Feb 07, 2022 BUY Buy
+334.0% avg upside
19 analysts
$4.80
370.60% Upside
 +89.5%
TRIP
TripAdvisor
 Sep 24, 2021 BUY Buy
+98.9% avg upside
42 analysts
$46.00
272.26% Upside
 -39.8%
TCEHY
Tencent Holdings
 Nov 02, 2020 BUY Strong Buy
+29.6% avg upside
18 analysts
 — -24.5%
HK:0772
China Literature
 Jul 21, 2020 BUY Strong Buy
+94.7% avg upside
7 analysts
 — ·
🔒 15 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Elinor Leung — Frequently Asked Questions
How accurate are Elinor Leung's stock ratings?
Based on the calls 13Foresight could measure, about 33% of Elinor's ratings were profitable over a one-year hold, with an average return of -4.2% per rating, or +0.0% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Elinor ranked on 13Foresight?
Elinor Leung is currently ranked #433 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Elinor cover?
Elinor most recently has ratings on HK:3690, HK:1024, HK:1810, HK:6618, HK:0700, BABA, BIDU, HK:0728, TCOM, JD, BILI, NTES and 8 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.